18 Apr 2024
18:00 CEST |
L'OREAL |
Chiffre d’affaires du 1er trimestre 2024
|
40204035 Cosmetics |
Sales |
18 Apr 2024
18:00 CEST |
KERLINK |
KERLINK : Résultats annuels 2023. Confiance dans les perspectives d’activité 2024.
|
15101010 Telecommunications Equipment |
General meeting / Board Meeting |
18 Apr 2024
18:00 CEST |
NEOLIFE |
Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE
|
50101035 Building Materials: Other |
- |
18 Apr 2024
18:00 CEST |
PRODWAYS GROUP |
Activité de 1er trimestre 2024 : 16 M EUR de revenus
|
50204050 Machinery: Specialty |
Sales, Income |
18 Apr 2024
18:00 CEST |
ONCODESIGN PRECISION MEDICINE |
Degroof Petercam initie la couverture d’Oncodesign Precision Medicine
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
ESSILORLUXOTTICA |
EssilorLuxottica: Chiffre d'affaires T1 2024 - Trajectoire solide du chiffre d’affaires au premier trimestre
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
18:00 CEST |
AELIS FARMA |
Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
INTEGRAGEN |
IntegraGen : Résultats annuels 2023 – Excédent brut d’exploitation positif reflétant la bonne maîtrise des coûts
|
20103010 Biotechnology |
Income |
18 Apr 2024
18:00 CEST |
INTEGRAGEN |
IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control
|
20103010 Biotechnology |
Income |
18 Apr 2024
18:00 CEST |
AMPLITUDE SURGICAL |
Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates
|
20102010 Medical Equipment |
Sales |
18 Apr 2024
18:00 CEST |
THERANEXUS |
Theranexus et BBDF annoncent les données finales et positives de sécurité et d'efficacité de Batten-1 dans l'étude de phase 1/2
|
20103010 Biotechnology |
Legal |
18 Apr 2024
18:00 CEST |
L'OREAL |
First quarter 2024 sales
|
40204035 Cosmetics |
Sales |
18 Apr 2024
18:00 CEST |
PRODWAYS GROUP |
Activity of the 1st quarter 2024: EUR 16 M in revenue
|
50204050 Machinery: Specialty |
Sales, Income |
18 Apr 2024
17:52 CEST |
DIAGNOSTIC MEDICAL SYSTEMS |
Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024
|
20102010 Medical Equipment |
Commercial results |
18 Apr 2024
17:47 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNONCE UN CHIFFRE D'AFFAIRES AU QUATRIEME TRIMESTRE EN CROISSANCE DE +12% A 59 M€
|
40203040 Electronic Entertainment |
Sales, Other subject |
18 Apr 2024
17:47 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNOUNCES FOURTH-QUARTER REVENUE GROWTH OF +12% TO €59M
|
40203040 Electronic Entertainment |
Sales, Other subject |
18 Apr 2024
17:45 CEST |
IPSOS |
Ipsos: Continued momentum in Q1
|
40301020 Media Agencies |
Income |
18 Apr 2024
17:45 CEST |
IPSOS |
Ipsos : Poursuite de la dynamique de croissance au 1er trimestre
|
40301020 Media Agencies |
Income |
18 Apr 2024
17:45 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: AHMED BOUKHELIFA APPOINTED DEPUTY CHIEF EXECUTIVE OFFICER OF PULLUP ENTERTAINMENT, IN CHARGE OF THE STUDIOS
|
40203040 Electronic Entertainment |
Other subject |
18 Apr 2024
17:45 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: NOMINATION D’AHMED BOUKHELIFA DIRECTEUR GÉNÉRAL DÉLÉGUE CHARGÉ DES STUDIOS
|
40203040 Electronic Entertainment |
Other subject |
18 Apr 2024
17:45 CEST |
CLASQUIN |
CLASQUIN : MISE A DISPOSITION DU RAPPORT ANNUEL 2023
|
50206040 Delivery Services |
Legal |
18 Apr 2024
17:45 CEST |
ARGAN |
ARGAN : Paiement du dividende en actions - 28 % de l’actionnariat y souscrit en 2024
|
35102030 Office REITs |
Change in Capital |
18 Apr 2024
17:45 CEST |
DAMARTEX |
DAMARTEX / Chiffre d’affaires des neuf premiers mois de l’exercice 2023/2024
|
40401020 Apparel Retailers |
Share history |
18 Apr 2024
17:45 CEST |
ORAPI |
Correction: ORAPI : Mise à disposition du Rapport Financier Annuel 2023
|
55201000 Chemicals: Diversified |
Other subject |
18 Apr 2024
17:45 CEST |
ARGAN |
ARGAN: Scrip dividend - Subscribed by 28% of the shareholding in 2024
|
35102030 Office REITs |
Change in Capital |
18 Apr 2024
17:43 CEST |
SPIE |
Press release - SPIE - Closing of the acquisition of ICG Group in Germany
|
50101015 Engineering and Contracting Services |
Mergers, Acquiqitions, Transferts |
18 Apr 2024
17:43 CEST |
SPIE |
Communiqué de presse - SPIE - Finalisation de l’acquisition de ICG Group en Allemagne
|
50101015 Engineering and Contracting Services |
Mergers, Acquiqitions, Transferts |
18 Apr 2024
17:40 CEST |
MERCIALYS |
Mercialys : Activité du 1er trimestre 2024
|
35102045 Retail REITs |
Other subject |
18 Apr 2024
17:40 CEST |
MERCIALYS |
Mercialys: 2024 First-quarter Activity
|
35102045 Retail REITs |
Other subject |
18 Apr 2024
17:30 CEST |
ORAPI |
ORAPI : Mise à disposition du Rapport Financier Annuel 2023
|
55201000 Chemicals: Diversified |
Other subject |
18 Apr 2024
17:05 CEST |
VIRTUALWARE |
Virtualware and Totalpower forge strategic partnership to introduce VIROO in Brazil
|
10101010 Computer Services |
- |
18 Apr 2024
17:00 CEST |
TXCOM |
TXCOM : Annulation de la promesse de ventes du 17/07/2023 par PITCH IMMO
|
15101010 Telecommunications Equipment |
New |
18 Apr 2024
16:11 CEST |
LVMH |
LVMH 2023 Dividend
|
40204020 Clothing and Accessories |
Other subject |
18 Apr 2024
16:11 CEST |
LVMH |
LVMH Dividende 2023
|
40204020 Clothing and Accessories |
Other subject |
18 Apr 2024
16:03 CEST |
GUILLEMOT |
GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 31/03/2024
|
10102030 Computer Hardware |
Other subject |
18 Apr 2024
16:03 CEST |
GUILLEMOT |
GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 31/03/2024
|
10102030 Computer Hardware |
Other subject |
18 Apr 2024
16:00 CEST |
INTERPARFUMS |
Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 16,2024
|
40204035 Cosmetics |
Other subject |
18 Apr 2024
16:00 CEST |
INTERPARFUMS |
Descriptif du programme de rachat d\'actions autorisé par l\'Assemblée générale mixte des actionnaires du 16 avril 2024
|
40204035 Cosmetics |
Other subject |
18 Apr 2024
15:00 CEST |
ATOS |
Atos renews its AWS Managed Service Provider (MSP) designation
|
10101010 Computer Services |
- |
18 Apr 2024
15:00 CEST |
ATOS |
Atos renouvelle son titre de fournisseur de services managés AWS (Managed Service Provider - MSP)
|
10101010 Computer Services |
- |
18 Apr 2024
14:27 CEST |
SCHNEIDER ELECTRIC SE |
Disclosure of Share Capital and Voting Rights Outstanding as of March 31,2024
|
50202010 Electrical Components |
Other subject |
18 Apr 2024
14:27 CEST |
SCHNEIDER ELECTRIC SE |
Nombre total de droits de vote et actions composant le capital social au 31 mars 2024
|
50202010 Electrical Components |
Other subject |
18 Apr 2024
13:14 CEST |
GENSIGHT BIOLOGICS |
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
|
20103010 Biotechnology |
Commercial operations |
18 Apr 2024
13:14 CEST |
GENSIGHT BIOLOGICS |
GenSight Biologics met à disposition son Document d’Enregistrement Universel 2023
|
20103010 Biotechnology |
Commercial operations |
18 Apr 2024
11:31 CEST |
LLEIDA |
L'opérateur postal néerlandais distribuera les services de Lleida.net en exclusivité aux Pays-Bas et pourra les vendre en Europe
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:31 CEST |
LLEIDA |
Dutch postal operator to distribute Lleida.net's services exclusively in the Netherlands, and will be able to sell in Europe
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:31 CEST |
LLEIDA |
El operador postal holandés distribuirá los servicios de Lleida.net en exclusiva en los Países Bajos, y podrá vender en Europa
|
10101020 Consumer Digital Services |
- |
18 Apr 2024
11:16 CEST |
VRANKEN-POMMERY |
Vranken-Pommery Monopole - Availability of the 2023 Reference Document (Including the Annual Financial Report)
|
45101015 Distillers and Vintners |
Other financial transaction |
18 Apr 2024
11:16 CEST |
VRANKEN-POMMERY |
VRANKEN-POMMERY MONOPOLE - MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2023 (incluant le Rapport Financier Annuel)
|
45101015 Distillers and Vintners |
Other financial transaction |
18 Apr 2024
11:15 CEST |
S.E.B. |
GROUPE SEB : NOMBRE D’ACTIONS ET DE DROITS DE VOTE A LA DATE DE PUBLICATION DE L’AVIS DE REUNION – 15.03.2024
|
40202025 Household Equipment and Products |
General meeting / Board Meeting |